Q4 2017 Advaxis Inc Earnings Call
Conference Call Advaxis Inc
Advaxis Inc Conference call or earnings call will be held on Dec 21, 2017 via an 800 number (toll-free). During the earnings conference call's session Advaxis Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Advaxis Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
Advaxis, Inc. ("Advaxis" or the "Company") is a clinical stage biotechnology company focused on the discovery, development and commercialization of proprietary Lm-LLO cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes ("Lm" or "Listeria" or "Lm TechnologyTM") bioengineered to secrete antigen/adjuvant fusion proteins. These Lm-LLO strains are believed to be a significant advancement in immunotherapy as they integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors.Read more Conference Call